News
-
-
PRESS RELEASE
PolyPeptide delivers strong revenue growth and marked improvement in profitability
PolyPeptide Group AG reports strong revenue growth of 15.6% to EUR 389.3 million in 2025, with EBITDA reaching EUR 46.8 million (+84.4%). 2026 guidance includes 20-25% revenue growth and rising EBITDA margin -
-
PRESS RELEASE
PolyPeptide successfully closes financial year 2025 with strong revenue growth and marked improvement in profitability
PolyPeptide Group AG successfully closes financial year 2025 with strong revenue growth and improved profitability. Revenue of approximately EUR 389 million, EBITDA margin between 11-12% -
-
-
-
-
-
PRESS RELEASE
PolyPeptide delivers +24% growth in H1 2025, successful ramp-up at its Belgian site, 2025 full-year guidance revised towards the upper end of the range
PolyPeptide Group reports +24% revenue growth in H1 2025, revises full-year guidance towards upper range. EBITDA improved to EUR 4.4 million, major investments in capacity expansion projects